TELA Bio, Inc. (TELA) NASDAQ
0.94
+0.0852(+10.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.94
+0.0852(+10.02%)
Currency In USD
| Previous Close | 0.85 |
| Open | 0.84 |
| Day High | 0.95 |
| Day Low | 0.84 |
| 52-Week High | 2.2 |
| 52-Week Low | 0.5 |
| Volume | 151,719 |
| Average Volume | 187,706 |
| Market Cap | 41.87M |
| PE | -1.18 |
| EPS | -0.79 |
| Moving Average 50 Days | 0.81 |
| Moving Average 200 Days | 1.09 |
| Change | 0.09 |
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire Inc.
Mar 10, 2026 8:05 PM GMT
MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will r
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 19, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Nov 13, 2025 9:21 PM GMT
MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered d